Lehrnbecher Thomas, Trusen Andreas, Deinlein Frank, Höcht Burkhard, Marx Alexander, Kühl Joachim
Department of Pediatrics, University of Würzburg, Germany.
Med Pediatr Oncol. 2003 Jan;40(1):13-7. doi: 10.1002/mpo.10202.
Lymphoproliferative disorder (LPD) is described in only a few children receiving chemotherapy for cancer. In all of them, an association between LPD and EBV (Epstein-Barr Virus) was found. We report on a patient who developed LPD not associated with EBV while receiving chemotherapy for relapsed acute lymphoblastic leukemia (ALL). Despite discontinuation of chemotherapy, administration of intravenous immunoglobulins and surgery the patient died. Growing experience with this disorder may allow better treatment options in the future and will show whether LPD not associated with EBV requires different therapeutic strategies.
淋巴细胞增生性疾病(LPD)仅在少数接受癌症化疗的儿童中被描述。在所有这些儿童中,均发现LPD与EBV(爱泼斯坦-巴尔病毒)之间存在关联。我们报告了一名在接受复发性急性淋巴细胞白血病(ALL)化疗时发生与EBV无关的LPD的患者。尽管停止了化疗、给予了静脉注射免疫球蛋白并进行了手术,但该患者仍死亡。随着对这种疾病经验的不断积累,未来可能会有更好的治疗选择,并且将表明与EBV无关的LPD是否需要不同的治疗策略。